Business Context and Reporting Period
Company: Superior Group of Companies, Inc. (SGC)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2025
Business Overview: The Company operates three segments: Branded Products (promotional products/uniforms), Healthcare Apparel (scrubs/protective gear), and Contact Centers (business process outsourcing). It is an accelerated filer and smaller reporting company.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Sales | $137.1 million | $138.8 million |
| Gross Margin | $50.4 million (36.8%) | $55.3 million (39.8%) |
| Net (Loss) Income | ($0.8) million | $3.9 million |
| Diluted EPS | ($0.05) | $0.24 |
| EBITDA | $3.5 million | $9.6 million |
| Cash from Operations | ($2.0) million | $9.4 million |
| Total Debt | $95.7 million | $86.0 million |
| Cash & Equivalents | $19.8 million | $22.0 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 1.3% year-over-year, driven by volume decreases in Branded Products (-0.7%) and Healthcare Apparel (-6.8%). Contact Centers sales increased 2.9%.
- Margin Compression: Consolidated gross margin rate dropped from 39.8% to 36.8%. Branded Products margins fell due to sourcing mix and lower pricing; Healthcare Apparel margins declined due to higher costs of goods.
- Profitability Shift: The Company reported a net loss of $0.8 million compared to net income of $3.9 million in the prior year. Pre-tax income swung from a $4.6 million profit to a $0.9 million loss.
- Cash Flow Reversal: Operating cash flow turned negative ($2.0 million used) compared to $9.4 million provided in Q1 2024, primarily due to lower sales, higher costs, and a $2.2 million increase in inventory.
- Debt Activity: Total debt increased by approximately $9.7 million, with the revolving credit facility balance rising from $22.0 million to $33.0 million.
Guidance, Outlook, and Risks
- Capital Allocation: The Board approved a new $17.5 million stock repurchase plan in March 2025. The Company repurchased $3.8 million of stock in Q1 2025. Cash dividends of $0.14 per share were maintained.
- Tariff Risks: Management highlights significant risk from recently enacted U.S. tariffs on finished products from China and other manufacturing regions. The Company is monitoring negotiations and evaluating sourcing alternatives to mitigate cost impacts.
- Geopolitical Factors: Risks include civil unrest in manufacturing locations (e.g., Haiti), global economic instability, and supply chain disruptions.
- Liquidity: Management believes current cash, operating cash flows, and the $125 million revolving credit facility are sufficient for the next 12 months. The Company remains in compliance with debt covenants (fixed charge coverage and net leverage ratios).
Investor Verification Checklist
- Tariff Impact: Verify the specific cost pass-through mechanisms and sourcing shifts implemented to counteract new U.S. tariffs on Chinese goods.
- Inventory Levels: Review the $98.5 million inventory balance and the $2.2 million cash outflow for inventory to assess potential obsolescence or demand slowdown risks.
- Debt Covenants: Confirm continued compliance with the 4.0x net leverage ratio and 1.25x fixed charge coverage ratio given the recent net loss.
- Segment Mix: Monitor the divergence between the declining Branded/Healthcare segments and the growing Contact Centers segment for long-term strategic alignment.
- Share Repurchases: Track the execution of the new $17.5 million buyback program against the backdrop of negative operating cash flow.